(12) United States Patent (10) Patent No.: US 6,633,772 B2 Ford Et Al
USOO6633772B2 (12) United States Patent (10) Patent No.: US 6,633,772 B2 Ford et al. (45) Date of Patent: Oct. 14, 2003 (54) FORMULATION AND MANIPULATION OF WO WO 96/00109 1/1996 DATABASES OF ANALYTE AND WO WO 97/02811 1/1997 ASSOCATED WALUES WO WO 99/58190 11/1999 WO WO OO/07013 A 2/2000 (75) Inventors: Russell Ford, Portola Valley, CA (US); WO WO OO/471.09 A 8/2000 Matthew J. Lesho, San Mateo, CA (US); Russell O. Potts, San Francisco, OTHER PUBLICATIONS CA (US); Michael J. Tierney, San Jose, CA (US); Charles W. Wei, Bolinder et al., “Self-Monitoring of Blood Glucose in Type Fremont, CA (US) I Diabetic Patients: Comparison with Continuous Microdi alysis Measurements of Glucose in Subcutaneous Adipose (73) Assignee: Cygnus, Inc., Redwood City, CA (US) Tissue During Ordinary Life Conditions,” Diabetes Care (*) Notice: Subject to any disclaimer, the term of this 20(1):64–70 (1997). patent is extended or adjusted under 35 Ohkubo et al., “Intensive Insulin Therapy Prevents the U.S.C. 154(b) by 0 days. Progression of Diabetic Microvascular Complications in Japanese patients with Non-Insulin-Dependent Diabetes (21) Appl. No.: 09/927,583 Mellitus: a Randomized Prospective 6-year Study,” Diabe (22) Filed: Aug. 10, 2001 tes Research & Clinical Practice 28:103–117 (1995). (65) Prior Publication Data (List continued on next page.) US 2002/0045808 A1 Apr. 18, 2002 O O Primary Examiner Robert L. Nasser Related U.S. Application Data (74) Attorney, Agent, or Firm-Barbara McClung; Gary (60) Provisional application No.
[Show full text]